1-6 of 6
Rose-Marie Hamljadi
Close
Sort by
Journal Articles

Current Outcome Of HLA Identical Sibling Vs Unrelated DONOR Transplants In Severe Aplastic Anemia : An EBMT Analysis

Andrea Bacigalupo, MD, Gérard Socié, MD, PhD, Rose-Marie Hamljadi, Mahmoud Aljurf, A Mashan, Slawomira Kyrcz-Krzemien, MD, A Cybicka, H Sengeloev, Ali Unal, MD, Dietrich Beelen, MD, A Locasciulli, Carlo Dufour, MD, Jakob R. Passweg, R Oneto, Judith Marsh
Journal: Blood
Blood (2013) 122 (21): 707.
https://doi.org/10.1182/blood.V122.21.707.707
Published: 2013
Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplant In Patients With Multiple Myeloma: A Comparison Of Planned Autologous-Reduced Intensity Allogeneic Stem Cell Transplant (Auto-Allo) and Reduced Intensity Allogeneic Stem Cell Transplant (RIC) As Upfront Transplant In Patients With Multiple Myeloma, An EBMT Analysis

Firoozeh Sahebi, MD, Simona Iacobelli, Ph. D., Anja Van Biezen, Liisa Volin, MD, Peter Dreger, Mauricette Michallet, MD, PhD, Per T. Ljungman, MD, PhD, Goesta Gahrton, MD, PhD, Curly TCM Morris, MD, Stefan Schonland, Theo de Witte, MD, Laurent Garderet, MD, Nicolaus Kroeger, MD, Anja Henseler, Nicolaas PM Schaap, MD, PhD, D Caballero, Xavier Poire, MD, Jakob Passweg, Rose-Marie Hamljadi
Journal: Blood
Blood (2013) 122 (21): 920.
https://doi.org/10.1182/blood.V122.21.920.920
Published: 2013
Journal Articles

Significance of Busulfan Dose Intensity On Outcomes of Hematopoietic Cell Allografting for AML in Second Complete Remission or Beyond: A Report From the EBMT Acute Leukemia Working Party

Ali Bazarbachi, MD, PhD, Myriam Labopin, Mohamed A. Kharfan-Dabaja, MD, Gérard Socié, MD PhD, Nicolaus Kröger, Didier Blaise, MD, Hendrik Veelken, MD PhD, Arancha Bermudez, Reuven Or, MD, Bruno Lioure, MD, Dietrich Beelen, Nathalie Fegueux, MD, Rose-Marie Hamljadi, Arnon Nagler, Mohamad Mohty, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1929.
https://doi.org/10.1182/blood.V120.21.1929.1929
Published: 2012
Journal Articles

Comparative Efficacy Analysis of Busulfan Dose Intensity Between Two Reduced Intensity Conditioning Regimens (FB2 vs. FB4) for Allogeneic HCT for AML in First Complete Remission: A Report From the EBMT Acute Leukemia Working Party

Mohamed A Kharfan-Dabaja, MD, Myriam Labopin, Ali Bazarbachi, MD, PhD, Rose-Marie Hamljadi, Didier Blaise, MD, Gérard Socié, MD PhD, Bruno Lioure, MD, Arancha Bermudez, MD, Dolores Caballero, MD, Reuven Or, MD, William Arcese, MD, Nathalie Fegueux, MD, Arnon Nagler, Mohamad Mohty, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4153.
https://doi.org/10.1182/blood.V120.21.4153.4153
Published: 2012
Journal Articles

Intravenous Busulfan (IV Bu)-Based Conditioning Regimen Before Allogeneic Stem Cell Transplantation (allo-SCT) for Adults with Acute Lymphoid Leukemia (ALL): A Aurvey From the Acute Leukemia Working Party of EBMT

Mohamad Mohty, Myriam Labopin, MD, MS, Miguel A. Sanz, MD, PhD, Rose-Marie Hamljadi, Vladimir Koza, MD, William Arcese, MD, Antonio Campos, Noel-Jean Milpied, MD, Arnon Nagler, MD
Journal: Blood
Blood (2011) 118 (21): 3005.
https://doi.org/10.1182/blood.V118.21.3005.3005
Published: 2011
Journal Articles

Pediatric Sibling Donor Complications of Hematopoietic Stem Cell Collection: EBMT Pediatric Diseases Working Party Study.

Jan Styczynski, Myriam Labopin, Nabila Elarouci, Adriana Balduzzi, Lidia Gil, Karoline Ehlert, Franca Fagioli, Rose-Marie Hamljadi, Sarah Marktel, Akif Yesilipek, Martina Matulova, Jean-Hugues Dalle, Massimo Berger, Jacek Wachowiak, Maurizio Miano, Stefania Varotto, Miguel Angel Diaz, Christiane Vermylen, Szymon Skoczen, Matthias Eyrich, Isabel Badell, Peter Dreger, Daphna Hutt, Jelena Rascon, Bozena Marianska, Ali Bazarbachi, Christina Peters, Giorgio Dini
Journal: Blood
Blood (2009) 114 (22): 806.
https://doi.org/10.1182/blood.V114.22.806.806
Published: 2009